Recruiting

Observational Study

Sponsor:

Vitaccess Ltd

Code:

NCT06064461

Conditions

Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records.

Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.

Conditions

Myasthenia Gravis

Study ID

NCT06064461

Start date

Jul 31, 2024

Status verified date

Jul, 2025

Completion date

Jul, 2034

Anticipated

Primary completion date

Jul, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult (age ≥18 years) with a clinically-confirmed diagnosis of myasthenia gravis (MG).
  • Resident in one of the scope countries.
  • Access to a smartphone/tablet/computer/laptop
  • Willing and able to provide informed consent in their local language to take part in the study.

Exclusion Criteria:

  • Participation in a clinical trial at the time of study enrolment.

Study Design

Enrollment

600 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • The Vitaccess Real MG Registry [ Time Frame: 10 years ]

Central Contacts and Locations

Central contacts

Mark JW Larkin, PhD

+44 1865818983mark.larkin@vitaccess.com

Locations

UCI Health

Recruiting

Orange, California, United States, 92868

Contacts

Ivonne Turner

714-456-7890imturner@hs.uci.edu

Principal Investigator:

Ali Habib, MD

HSHS St. Elizabeth's Hospital

Recruiting

O'Fallon, Illinois, United States, 62269

Contacts

Beth J Corbett

bcorbett@prairieresearch.com

Principal Investigator:

Raghav Govindarajan, MD

UK HealthCare - University of Kentucky

Recruiting

Lexington, Kentucky, United States, 40536

Contacts

Research Associate Clinical I/UKHC

+1 (859) 323-5000

Principal Investigator:

Zabeen Mahuwala, MD

Neurology Associates of South Jersey

Recruiting

Lumberton, New Jersey, United States, 08048

Contacts

Mayank Mathur, MD

vrmg@vitaccess.com

Medical University South Carolina

Recruiting

Charleston, South Carolina, United States, 29425

Contacts

Alison Line

843-792-2845line@musc.edu

Principal Investigator:

Katherine Ruzhansky, MD

University of Texas Health Science Center at Houston

Recruiting

Houston, Texas, United States, 77030

Contacts

Christine Farrell

713-486-0500christine.m.farrell@uth.tmc.edu

Principal Investigator:

Thy Nguyen, MD

More Information

Sponsor

Vitaccess Ltd

Last update posted

Jul 29, 2025

Last verified

Jul, 2025

Keywords

  • Myasthenia Gravis
  • patient registry
  • longitudinal
  • observational data

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-24. This information was provided to ClinicalTrials.gov by Vitaccess Ltd on 2025-07-29. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.